2012/02/02

Dihydroxypentamethoxyflavone down-regulates constitutive and induciblesignal transducers and activators of transcription-3 through the induction oftyrosine phosphatase SHP-1.


Mol Pharmacol. 2011 Nov;80(5):889-99. Epub 2011 Aug 4.

Dihydroxypentamethoxyflavone down-regulates constitutive and induciblesignal transducers and activators of transcription-3 through the induction oftyrosine phosphatase SHP-1.

Phromnoi K, Prasad S, Gupta SC, Kannappan R, Reuter S, Limtrakul P, Aggarwal BB.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.






Written by Time: 0 件のコメント:

Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulatedgene products involved in cell survival, proliferation, invasion, andinflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis.


Blood. 2008 May 15;111(10):4880-91. Epub 2008 Mar 18.

Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulatedgene products involved in cell survival, proliferation, invasion, andinflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis.

Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, Aggarwal BB.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, USA.

Fig 4A - last 2 lanes on the right (AA30 and 60) are cloned.






Written by Time: 0 件のコメント:

Zyflamend Sensitizes Tumor Cells to TRAIL-Induced Apoptosis Through Up-Regulation of Death Receptors and Down-Regulation of Survival Proteins: Roleof ROS-Dependent CCAAT/Enhancer-Binding Protein-Homologous ProteinPathway.


Antioxid Redox Signal. 2012 Mar 1;16(5):413-27. Epub 2011 Dec 15.

Zyflamend Sensitizes Tumor Cells to TRAIL-Induced Apoptosis Through Up-Regulation of Death Receptors and Down-Regulation of Survival Proteins: Roleof ROS-Dependent CCAAT/Enhancer-Binding Protein-Homologous ProteinPathway.

Kim JH, Park B, Gupta SC, Kannappan R, Sung B, Aggarwal BB.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center , Houston, Texas.








Written by Time: 0 件のコメント:

Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21and p27 in multiple human tumor cell lines.


Biochem Pharmacol. 2007 Apr 1;73(7):1024-32. Epub 2006 Dec 15.

Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21and p27 in multiple human tumor cell lines.

Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. aggarwal@mdanderson.org







Written by Time: 0 件のコメント:

Evidence for the critical roles of NF-κB p65 and specificity proteins in the apoptosis-inducing activity of proteasome inhibitors in leukemia cells.


Biochim Biophys Acta. 2012 Jan 10. [Epub ahead of print]

Evidence for the critical roles of NF-κB p65 and specificity proteins in the apoptosis-inducing activity of proteasome inhibitors in leukemia cells.

Reuter S, Gupta SC, Kannappan R, Aggarwal BB.















Written by Time: 0 件のコメント:

Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.


Cancer Lett. 2011 Dec 17. [Epub ahead of print]

Cardamonin inhibits osteoclastogenesis induced by tumor cells throughinterruption of the signaling pathway activated by receptor activator of NF-κBligand.

Yadav VR, Prasad S, Reuter S, Sung B, Yamamoto N, Murakami A, Aggarwal BB.

Source

Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.










WITHDRAWN:



This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.
The full Elsevier Policy on Article Withdrawal can be found at　http://www.elsevier.com/locate/withdrawalpolicy.


Retraction Watch:

MD Anderson researcher Aggarwal loses paper in Cancer Letters




Written by Time: 0 件のコメント:
登録: 投稿 (Atom)